Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antitussive Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118993872A details a novel three-step refining process for Fendithiino Acid ensuring high purity and stable supply chain for global pharmaceutical manufacturing partners.
Patent CN103073496A reveals a streamlined N-methylation route for Dextromethorphan, eliminating genotoxic impurities and reducing manufacturing costs for API intermediates.
Patent CN101883761B reveals a novel Moguisteine synthesis route using stable cyclic intermediates, offering significant cost reduction and high-purity pharmaceutical manufacturing advantages.
Patent CN108752290B details a high-yield TTP/HFIP catalytic route for benproperine phosphate, offering significant cost reduction and purity improvements for API manufacturers.